New Expert Consensus Sets Standard Surgical Framework for Unilateral Wilms Tumor

Sequencio Therapeutics to Present Preclinical Data on Two Cancer Vaccine Candidates at SITC 2026

Kairos Pharma’s ENV-105 Shows Significant Survival Benefit in Prostate Cancer Trial

Ultrasound Method Shows Promise for Delivering Brain Cancer Treatment

New Expert Consensus Aims to Standardize Surgery for Childhood Kidney Cancer

Mayo Clinic Study Finds Brain Tumor DNA in Cerebrospinal Fluid, Offering Less Invasive Diagnostic Path

Rural Heart Attack Deaths Nearly Triple Compared to Urban Areas, Study Finds

New Estimates Put Annual Nonmelanoma Skin Cancer Diagnoses at 4.7 Million in the U.S.

VERAXA Biotech Expands Human-Relevant Testing to Advance BiTAC Cancer Therapies

Dual-Targeting Antibody Shows Potential to Broaden Cancer Immunotherapy Reach

TransCode Therapeutics Launches Strategic Review to Maximize Value of Oncology Portfolio

Immunotherapy Combination Nearly Doubles Survival in Deadly Lung Cancer Trial

VolitionRx Signs LOI with Missionpharma to Develop NETosis Diagnostic for Neonatal Sepsis

American Heart Association Expands Online Support Network for Heart and Stroke Survivors

Creative Biolabs Highlights Tumor Organoid Co-Culture Models for CAR-T Research

Creative Biolabs Launches Dual-Vesicle Platform to Tackle Solid Tumor Barriers in CAR-T Research

TransCode Therapeutics Reports Positive Phase 1a Safety Results for TTX-MC138 at ESMO Congress 2026

Oncotelic’s AI Platform Identifies Four-Gene Signature in Liver Cancer, Published in Biomedicines

Coherence Neuro Raises $45 Million to Advance Brain Implant for Glioblastoma

Yale Study Finds Brain Cancers Develop Distinct Mutations After Treatment, Opening Path to Personalized Therapy

ECGI Holdings Engages IBN to Boost Investor Awareness of Its Healthcare Strategy

VERAXA Biotech Adopts Human-Relevant Testing to Speed Antibody Cancer Pipeline

VERAXA Biotech’s Dual-Targeting Strategy Aims to Sharpen Cancer Therapy Precision

Bangladesh’s Measles Outbreak Surpasses 200,000 Suspected Cases, Sounds Alarm for Global Vaccination Efforts

VERAXA Biotech Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline

Dr. Mona Mofid Named San Diego Top Doctor for Ninth Year, Earns Patient Satisfaction and Specialist Awards

Pentixapharm Builds International Evidence for Non-Invasive Primary Aldosteronism Subtyping Ahead of Phase 3 PANDA

New Brain Tumor Vaccine Shows Long-Term Survival Benefits in Early Study

TransCode Therapeutics to Present Updated Phase 1a TTX-MC138 Data at ESMO Congress 2026

Creative BioTherapeutics Named 2026 Prix Galien USA Best Startup Nominee for CBT300

Experimental Vaccine Shows Promise in Glioblastoma Trial, Offering New Hope After Decades of Stagnation

AI and Advanced Imaging Transform Breast Cancer Detection, Survival Rates Climb

VERAXA Biotech Unveils First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

Clearing ‘Immune Fog’ May Stop Lung Cancer Before It Starts, Study Finds

VERAXA Biotech Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

Study Uncovers SPRED2/p53/miR-506-3p/KLF4 Axis Driving Liver Cancer Stemness

Expanding High Blood Pressure Control Could Save Over 518,000 Lives Annually in 20 Countries

Flu Season Off to Early Start in the U.S., Raising Concerns About Diagnostic Capacity

Consultwebs Offers Paid Time Off and Stipend for Mammograms During Breast Cancer Awareness Month

Avident Health and Unite for HER Receive Quality Improvement Grant to Enhance Metastatic Breast Cancer Care

ACR Urges Breast Cancer Risk Assessment by Age 25, Especially for Black and Ashkenazi Jewish Women

VERAXA Biotech Advances FDA-Aligned Methods to Reduce Animal Testing in Cancer Research

Lantern Pharma Wins Taiwan Approvals for Phase 2 HARMONIC Trial of LP-300 in Lung Cancer

VERAXA Biotech Advances FDA-Aligned Methods to Cut Animal Testing in Cancer Drug Development

Telomir Pharmaceuticals Secures $5.6 Million PIPE Financing to Advance Telomir-Zn Clinical Program

Skull’s Hidden Lymph Node-Like Structures May Give Brain a Local Immune Defense, Study Finds

Kairos Pharma’s ENV-105 Shows Significant Progression-Free Survival Benefit in Phase 2 Prostate Cancer Trial

GeoVax to Present Single-Dose MVA Vaccine and Scalable Manufacturing Advances at World Vaccine Congress Europe 2026

HKCEC Hosts 786 Events in FY 2025-2026, Secures Return of Major Debuts

NHS Rapid Brain Tumor Test Cuts Diagnosis Wait from Eight Weeks to Two Hours

Blood-Based Approach May Broaden Access to Personalized Cancer Immunotherapy

Mega Bee Goes Pink for Breast Cancer Awareness, Donates 5% of October Services

Three Million UK Children Forecast to Develop Myopia by 18, Prompting Calls for Early Eye Tests

Blue Faery to Host Free Liver Cancer Education Event in Chicago

Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing Scale-Up and $5M Financing

Billions of Pounds of Cancer-Linked Chemicals Entered U.S. Air in 2020, Highlighting Gaps in Prevention and Treatment

BIOT Appointed Authorized Representative for IN01 Cancer Immunotherapy in Japan and China

Nashville Clinic Highlights Overlooked Link Between Adult ADHD and Sleep Deprivation

VERAXA Biotech Advances VXA-222 Bispecific ADC to Final Candidate Engineering, Bolstering Oncology Pipeline

Nutriband CEO Gareth Sheridan Featured in New Opioid Crisis Documentary, Highlights AVERSA Abuse-Deterrent Technology